4-iodoamphetamine has been researched along with Cerebrovascular Moyamoya Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimura, M; Inoue, T; Mugikura, S; Saito, A; Shimizu, H; Tominaga, T | 1 |
| Khonsary, A; Miller, JH; Raffel, C | 1 |
2 other study(ies) available for 4-iodoamphetamine and Cerebrovascular Moyamoya Disease
| Article | Year |
|---|---|
Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease.
Topics: Adolescent; Adult; Aged; Amphetamines; Anastomosis, Surgical; Antihypertensive Agents; Autoradiography; Blood Pressure; Cerebral Hemorrhage; Cerebral Revascularization; Cerebrovascular Circulation; Cerebrovascular Disorders; Child; Child, Preschool; Clinical Protocols; Female; Humans; Male; Middle Aged; Moyamoya Disease; Odds Ratio; Postoperative Care; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Young Adult | 2012 |
The scintigraphic appearance of childhood moyamoya disease on cerebral perfusion imaging.
Topics: Adolescent; Adult; Amphetamines; Brain; Cerebral Angiography; Cerebrovascular Circulation; Child; Child, Preschool; Female; Humans; Magnetic Resonance Angiography; Male; Moyamoya Disease; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1996 |